Author: Biz India

Book Review: Cambridge Handbook of Disaster Risk Reduction and International Law

Book Review: Cambridge Handbook of Disaster Risk Reduction and International Law

Posted by | Apr 19, 2020 |

Editors: Katja L. H. Samuel, Marie Aronsson-Storrier, and Kirsten Nakjavani Bookmiller Publisher:  Cambridge University Press – 509 pages Book Review by: Sonu Chandiram We face today (April 18, 2020) one of the greatest and at the same time strangest disasters in human history – entitled the Global Coronavirus Pandemic, also known as Covid-19, as named by the World Health Organization (WHO). The number 19 refers to the fact that this disaster emerged on December 1 in the year 2019. From the city of Wuhan in the province of Hubei in southern China, it has spread into almost all countries...

Read More
Book Review: The Future of Economic and Social Rights

Book Review: The Future of Economic and Social Rights

Posted by | Apr 18, 2020 |

Editor: Katherine G. Young Publisher:  Cambridge University Press – 683 pages Book Review by: Sonu Chandiram Economic and social rights are an important par, yet often overlooked part of the wide range of human rights, contends the editor of this book Katherine Young. But here is the present and past situation with them, she points out – they are essentially: Neglected within the human rights movement Avoided by courts Subsumed with a single-minded conception of development as economic growth, economic and social rights faced an uncertain status in internal human rights law and in the public laws of most...

Read More
Antiviral remdesivir prevents disease progression in monkeys with COVID-19

Antiviral remdesivir prevents disease progression in monkeys with COVID-19

Posted by | Apr 17, 2020 |

Study supports clinical testing under way across U.S. April 17, 2020 – Scientists at the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health (NIH), reported today that early treatment with the experimental antiviral drug remdesivir, developed by Gilead Sciences of Foster City, California, significantly reduced clinical disease and damage to the lungs of rhesus macaques infected with SARS-CoV-2, the coronavirus that causes COVID-19. The study was designed to follow dosing and treatment procedures used for hospitalized COVID-19 patients being administered remdesivir in a large, multi-center, clinical trial led by the NIAID. The scientists posted...

Read More
Early peek at data on Gilead coronavirus drug suggests patients are responding to treatment

Early peek at data on Gilead coronavirus drug suggests patients are responding to treatment

Posted by | Apr 16, 2020 |

By Adam Feuerstein and Matthew Herper – STATNews Shown here is a vial of the Remdesivir, an investigational drug from Gilead. Image credit: Gilead, via AP. April 16, 2020 – A Chicago hospital treating severe Covid-19 patients with Gilead Sciences’ antiviral medicine Remdesivir in a closely watched clinical trial is seeing rapid recoveries in fever and respiratory symptoms, with nearly all patients discharged in less than a week, STAT has learned. Remdesivir was one of the first medicines identified as having the potential to impact SARS-CoV-2, the novel coronavirus that causes Covid-19, in lab tests. The entire world has been waiting for...

Read More

Chris Cuomo Shares a Key to Battling Coronavirus After ‘Scary’ Chest X-Ray

Posted by | Apr 14, 2020 |

The CNN anchor said he learned to fight back after a sleepless night and a scan he struggled to understand at first. By Josephine Harvey | Huffington Post     “When you get a fever spike, and that hurts, he said you can’t take confidence that it’s going to go down … ‘You’ve got to layer up, you’ve got to drink, you’ve gotta take Tylenol, and you’ve gotta fight back. You’ve gotta make that fever go down any way you can.’” Cuomo revealed that he has an IgM deficiency, a rare immune disorder that makes him more susceptible to infections. The virus is “banking on you doing nothing,” Cuomo said. “Your indolence, as the doctors call it. It wants us passive, on our backs.” Earlier in the program, Cuomo and CNN’s chief medical correspondent Dr. Sanjay Gupta reviewed X-rays of his lungs that showed some infiltrate, which Gupta explained was a collection of inflammatory fluid and an indicator of a respiratory infection. Still, he said Cuomo’s lungs were looking “pretty good” and he would not diagnose him with...

Read More

Advertisement

Edison Volvo

Advertisement

AJ Jersey